1. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (10th December 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer. (10th December 2020) Authors: Paprcka, Susan; Udyavar, Akshata; Sridhar, Subhasree; Miles, Dillon; Chen, Yu; Cho, Sean; Foley, Corinne; Grange, Rebecca; Leleti, Manmohan; Zhao, Sharon; Jin, Lixia; Young, Stephen; Powers, Jay; Walters, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6). (9th November 2020) Authors: Udyavar, Akshata; Cecchini, Michael; DiRenzo, Daniel; Cho, Sean; Seitz, Lisa; Zhang, Kristen; Young, Stephen; Anderson, Amy; Gerrick, Kimberline; Walters, Matthew; Gilbert, Houston; Gardner, Olivia; Quah, Cheng; Jaen, Juan; Grossman, William Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗